These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 22944189)

  • 1. The Spanish pictogram on medicines and driving: The population's comprehension of and attitudes towards its use on medication packaging.
    Fierro I; Gómez-Talegón T; Alvarez FJ
    Accid Anal Prev; 2013 Jan; 50():1056-61. PubMed ID: 22944189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How effective are pictograms in communicating risk about driving-impairing medicines?
    Monteiro SP; Huiskes R; Van Dijk L; Van Weert JC; De Gier JJ
    Traffic Inj Prev; 2013; 14(3):299-308. PubMed ID: 23441949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of a Japanese drug alert pictogram on medication-taking/driving behavior.
    Fukuda Y; Ando S; Saito M
    Traffic Inj Prev; 2020; 21(1):18-23. PubMed ID: 31770002
    [No Abstract]   [Full Text] [Related]  

  • 4. Development and evaluation of pictograms on medication labels for patients with limited literacy skills in a culturally diverse multiethnic population.
    Kheir N; Awaisu A; Radoui A; El Badawi A; Jean L; Dowse R
    Res Social Adm Pharm; 2014; 10(5):720-30. PubMed ID: 24355379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of drivers with high versus low perceived risk of being caught and arrested for driving under the influence of alcohol.
    Beck KH; Fell JC; Yan AF
    Traffic Inj Prev; 2009 Aug; 10(4):312-9. PubMed ID: 19593706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Consumer perceptions of medication warnings about driving: a comparison of French and Australian labels.
    Smyth T; Sheehan M; Siskind V; Mercier-Guyon C; Mallaret M
    Traffic Inj Prev; 2013; 14(6):557-64. PubMed ID: 23859486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of the acceptance of a handbook for safe driving at an older age.
    Vardaki S; Yannis G
    Int J Inj Contr Saf Promot; 2012; 19(1):27-36. PubMed ID: 21736438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmaceutical pictograms: a model for development and testing for comprehension and utility.
    Montagne M
    Res Social Adm Pharm; 2013; 9(5):609-20. PubMed ID: 23680485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of chronic pain patients' psychotropic drug knowledge and warning labels on the decision whether to drive a car or not.
    Veldhuijzen DS; van Wijck AJ; Verster JC; Kalkman CJ; Kenemans JL; Olivier B; Volkerts ER
    Traffic Inj Prev; 2006 Dec; 7(4):360-4. PubMed ID: 17114093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hospital outpatients' responses to taking medications with driving warnings.
    Smyth T; Sheehan M; Siskind V
    Traffic Inj Prev; 2013; 14(1):18-25. PubMed ID: 23259515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of driver factors and sign design features on the comprehensibility of traffic signs.
    Ng AW; Chan AH
    J Safety Res; 2008; 39(3):321-8. PubMed ID: 18571574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Fitness-to-drive assessment in drivers with neurological and neuromuscular disorders at the driving test centres].
    Gómez-Talegón MT; Fierro I; Vicondoa A; Ozcoidi-Val M; Alvarez FJ
    Rev Neurol; 2007 Nov 1-15; 45(9):526-31. PubMed ID: 17979082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The presence of pathological processes among spanish drivers: its relevance to road safety].
    Prada Pérez R; del Río Gracia MC; Alvarez González FJ
    Rev Esp Salud Publica; 1995; 69(6):499-508. PubMed ID: 8789362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perceived risk, resources, and perceptions concerning driving and epilepsy: a patient perspective.
    Elliott JO; Long L
    Epilepsy Behav; 2008 Aug; 13(2):381-6. PubMed ID: 18539086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk and threat factors in prior representations of driving situations among powered two-wheeler riders and car drivers.
    Ragot-Court I; Mundutéguy C; Fournier JY
    Accid Anal Prev; 2012 Nov; 49():96-104. PubMed ID: 23036386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of an illustrated medication schedule as a low-literacy patient education tool.
    Kripalani S; Robertson R; Love-Ghaffari MH; Henderson LE; Praska J; Strawder A; Katz MG; Jacobson TA
    Patient Educ Couns; 2007 Jun; 66(3):368-77. PubMed ID: 17344015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Spanish drivers' valuation of the penalty point system].
    Roca Ruiz J; Montoro González L; Tortosa Gil F
    Psicothema; 2009 May; 21(2):294-9. PubMed ID: 19403085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A study comparing the effectiveness of three warning labels on the package of driving-impairing medicines.
    Emich B; van Dijk L; Monteiro SP; de Gier JJ
    Int J Clin Pharm; 2014 Dec; 36(6):1152-9. PubMed ID: 25204257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Family physicians' attitudes and practices regarding assessments of medical fitness to drive in older persons.
    Jang RW; Man-Son-Hing M; Molnar FJ; Hogan DB; Marshall SC; Auger J; Graham ID; Korner-Bitensky N; Tomlinson G; Kowgier ME; Naglie G
    J Gen Intern Med; 2007 Apr; 22(4):531-43. PubMed ID: 17372806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fitness to drive in multiple sclerosis: awareness of deficit moderates risk.
    Ryan KA; Rapport LJ; Telmet Harper K; Fuerst D; Bieliauskas L; Khan O; Lisak R
    J Clin Exp Neuropsychol; 2009 Jan; 31(1):126-39. PubMed ID: 18608652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.